ACTA1 and breast cancer: In the mouse breast cancer models, genetic deletion of CXCR4 in stromal cells expressing the αSMA marker decreased fibrosis, increased T-cell infiltration, and enhanced sensitivity to checkpoint inhibition (Chen et al., 2019).